David Lebwohl, EVP, Chief Medical Officer at Intellia Therapeutics, Inc. (NTLA), sold 5,148 shares at $37.21 ($192K) on 2023-01-04, disclosed to the SEC on 2023-01-06.
Open-market sale of $192k NTLA by EVP, Chief Medical Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $37.21 | 2,574 | $96K | 50.0% |
| 2 | $37.21 | 2,574 | $96K | 50.0% |
| Total | $37.21 avg | 5,148 | $192K | 100% |
| Filing → |
| NTLA | SELL | 2024-01-05 | $344K | — | Filing → |
| NTLA | SELL | 2022-03-03 | $236K | — | Filing → |
| NTLA | SELL | 2021-11-09 | $452K | — | Filing → |